» Authors » Harvinder S Virk

Harvinder S Virk

Explore the profile of Harvinder S Virk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 17
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ayoubi R, Ryan J, Gonzalez Bolivar S, Alende C, Ruiz Moleon V, Fotouhi M, et al.
Nat Protoc . 2024 Dec; PMID: 39690206
Antibody-based research applications are critical for biological discovery. Yet there are no industry standards for comparing the performance of antibodies in various applications. We describe a knockout cell line-based antibody...
2.
Leavy O, Goemans A, Stockwell A, Allen R, Guillen-Guio B, Hernandez-Beeftink T, et al.
medRxiv . 2024 Jan; PMID: 38293162
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition that is more prevalent in males than females. The reasons for this are not fully understood, with differing environmental exposures...
3.
Biddle M, Virk H
F1000Res . 2023 Oct; 12:1344. PMID: 37854875
YCharOS is a collaborative initiative aimed at characterising antibodies against the entire human proteome. As of August 2023, they have presented comprehensive knockout characterisation data for 812 antibodies and 78...
4.
Kahn R, Virk H, McPherson P
Nature . 2023 Aug; 620(7974):492. PMID: 37582877
No abstract available.
5.
Ayoubi R, Ryan J, Biddle M, Alshafie W, Fotouhi M, Gonzalez Bolivar S, et al.
bioRxiv . 2023 Jul; PMID: 37398479
Antibodies are critical reagents to detect and characterize proteins. It is commonly understood that many commercial antibodies do not recognize their intended targets, but information on the scope of the...
6.
Merchant F, Mavilakandy A, Virk H, Khan S, Tsaknis G, Naeem M, et al.
Open Respir Med J . 2023 Jun; 15:e187430642206271. PMID: 37273464
Background: Severe COVID-19 pneumonitis in elderly frail patients is associated with poor outcomes, and therefore invasive mechanical ventilation is often deemed an inappropriate course of action. Some evidence suggests high-flow...
7.
Virk H, Biddle M, Smallwood D, Weston C, Castells E, Bowman V, et al.
Br J Pharmacol . 2021 Mar; 178(15):2948-2962. PMID: 33786825
Background And Purpose: TGFβ1-mediated myofibroblast activation contributes to pathological fibrosis in many diseases including idiopathic pulmonary fibrosis (IPF), where myofibroblast resistance to oxidant-mediated apoptosis is also evident. We therefore investigated...